The human kallikrein 10 promoter contains a functional retinoid response element

Musheng Zeng, Ying Zhang, Ishfaq Bhat, David E. Wazer, Hamid Band, Vimla Band

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Human kallikrein 10 (hK10) protein is expressed in normal breast but is significantly downregulated in a majority of invasive breast cancers. Thus, understanding how hK10 expression is regulated is of substantial significance. In this study, we analyzed the promoter region of hK10 using a website software (TRANSFAC 3.0), which predicted three possible retinoic acid response elements (RAREs), RARE1 at -1041 (TGACCTCGTGATCC), RARE2 at -859 (TGACCTCCTATGA) and RARE3 at -765 (TGACCTCCTGTGA), each with a half-site of a canonical sequence (TGACCT; reverse complement AGGTCA). Using electrophoretic mobility shift assays and nucleotide competition analysis, as well as chromatin immunoprecipitation of the native hK10 promoter, we demonstrated specific binding of RXR only to RARE1. The functional importance of RARE in the hK10 promoter was demonstrated by retinoid induction of hk10 promoter-reporters; furthermore, mutation of RARE1 but not of RARE2 or RARE3 abolished the induction of the reporter. Finally, we demonstrated the induction of hK10 mRNA and protein expression upon retinoid treatment of cells. In view of the correlation of the downregulation of hK10 mRNA and protein with breast cancer progression, these findings suggest a potential approach to restore hK10 expression in cancer patients.

Original languageEnglish (US)
Pages (from-to)741-747
Number of pages7
JournalBiological Chemistry
Volume387
Issue number6
DOIs
StatePublished - Jun 1 2006
Externally publishedYes

Fingerprint

Kallikreins
Retinoids
Response Elements
Tretinoin
Down-Regulation
Breast Neoplasms
Messenger RNA
Chromatin Immunoprecipitation
Electrophoretic Mobility Shift Assay
Genetic Promoter Regions
Electrophoretic mobility
Breast
Software
Nucleotides
Chromatin
Websites
Mutation
Assays
Proteins
Cells

Keywords

  • Breast cancer
  • Kallikrein 10
  • RAR
  • RXR
  • Retinoic acid response element

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Clinical Biochemistry

Cite this

The human kallikrein 10 promoter contains a functional retinoid response element. / Zeng, Musheng; Zhang, Ying; Bhat, Ishfaq; Wazer, David E.; Band, Hamid; Band, Vimla.

In: Biological Chemistry, Vol. 387, No. 6, 01.06.2006, p. 741-747.

Research output: Contribution to journalArticle

Zeng, Musheng ; Zhang, Ying ; Bhat, Ishfaq ; Wazer, David E. ; Band, Hamid ; Band, Vimla. / The human kallikrein 10 promoter contains a functional retinoid response element. In: Biological Chemistry. 2006 ; Vol. 387, No. 6. pp. 741-747.
@article{c2158d1680fc4334a650ca2823761eef,
title = "The human kallikrein 10 promoter contains a functional retinoid response element",
abstract = "Human kallikrein 10 (hK10) protein is expressed in normal breast but is significantly downregulated in a majority of invasive breast cancers. Thus, understanding how hK10 expression is regulated is of substantial significance. In this study, we analyzed the promoter region of hK10 using a website software (TRANSFAC 3.0), which predicted three possible retinoic acid response elements (RAREs), RARE1 at -1041 (TGACCTCGTGATCC), RARE2 at -859 (TGACCTCCTATGA) and RARE3 at -765 (TGACCTCCTGTGA), each with a half-site of a canonical sequence (TGACCT; reverse complement AGGTCA). Using electrophoretic mobility shift assays and nucleotide competition analysis, as well as chromatin immunoprecipitation of the native hK10 promoter, we demonstrated specific binding of RXR only to RARE1. The functional importance of RARE in the hK10 promoter was demonstrated by retinoid induction of hk10 promoter-reporters; furthermore, mutation of RARE1 but not of RARE2 or RARE3 abolished the induction of the reporter. Finally, we demonstrated the induction of hK10 mRNA and protein expression upon retinoid treatment of cells. In view of the correlation of the downregulation of hK10 mRNA and protein with breast cancer progression, these findings suggest a potential approach to restore hK10 expression in cancer patients.",
keywords = "Breast cancer, Kallikrein 10, RAR, RXR, Retinoic acid response element",
author = "Musheng Zeng and Ying Zhang and Ishfaq Bhat and Wazer, {David E.} and Hamid Band and Vimla Band",
year = "2006",
month = "6",
day = "1",
doi = "10.1515/BC.2006.093",
language = "English (US)",
volume = "387",
pages = "741--747",
journal = "Biological Chemistry",
issn = "1431-6730",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "6",

}

TY - JOUR

T1 - The human kallikrein 10 promoter contains a functional retinoid response element

AU - Zeng, Musheng

AU - Zhang, Ying

AU - Bhat, Ishfaq

AU - Wazer, David E.

AU - Band, Hamid

AU - Band, Vimla

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Human kallikrein 10 (hK10) protein is expressed in normal breast but is significantly downregulated in a majority of invasive breast cancers. Thus, understanding how hK10 expression is regulated is of substantial significance. In this study, we analyzed the promoter region of hK10 using a website software (TRANSFAC 3.0), which predicted three possible retinoic acid response elements (RAREs), RARE1 at -1041 (TGACCTCGTGATCC), RARE2 at -859 (TGACCTCCTATGA) and RARE3 at -765 (TGACCTCCTGTGA), each with a half-site of a canonical sequence (TGACCT; reverse complement AGGTCA). Using electrophoretic mobility shift assays and nucleotide competition analysis, as well as chromatin immunoprecipitation of the native hK10 promoter, we demonstrated specific binding of RXR only to RARE1. The functional importance of RARE in the hK10 promoter was demonstrated by retinoid induction of hk10 promoter-reporters; furthermore, mutation of RARE1 but not of RARE2 or RARE3 abolished the induction of the reporter. Finally, we demonstrated the induction of hK10 mRNA and protein expression upon retinoid treatment of cells. In view of the correlation of the downregulation of hK10 mRNA and protein with breast cancer progression, these findings suggest a potential approach to restore hK10 expression in cancer patients.

AB - Human kallikrein 10 (hK10) protein is expressed in normal breast but is significantly downregulated in a majority of invasive breast cancers. Thus, understanding how hK10 expression is regulated is of substantial significance. In this study, we analyzed the promoter region of hK10 using a website software (TRANSFAC 3.0), which predicted three possible retinoic acid response elements (RAREs), RARE1 at -1041 (TGACCTCGTGATCC), RARE2 at -859 (TGACCTCCTATGA) and RARE3 at -765 (TGACCTCCTGTGA), each with a half-site of a canonical sequence (TGACCT; reverse complement AGGTCA). Using electrophoretic mobility shift assays and nucleotide competition analysis, as well as chromatin immunoprecipitation of the native hK10 promoter, we demonstrated specific binding of RXR only to RARE1. The functional importance of RARE in the hK10 promoter was demonstrated by retinoid induction of hk10 promoter-reporters; furthermore, mutation of RARE1 but not of RARE2 or RARE3 abolished the induction of the reporter. Finally, we demonstrated the induction of hK10 mRNA and protein expression upon retinoid treatment of cells. In view of the correlation of the downregulation of hK10 mRNA and protein with breast cancer progression, these findings suggest a potential approach to restore hK10 expression in cancer patients.

KW - Breast cancer

KW - Kallikrein 10

KW - RAR

KW - RXR

KW - Retinoic acid response element

UR - http://www.scopus.com/inward/record.url?scp=33745660354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745660354&partnerID=8YFLogxK

U2 - 10.1515/BC.2006.093

DO - 10.1515/BC.2006.093

M3 - Article

VL - 387

SP - 741

EP - 747

JO - Biological Chemistry

JF - Biological Chemistry

SN - 1431-6730

IS - 6

ER -